My Personal Vision
Blog
Robert
Publications

Plenge Lab

willy-wonka-gene-wilder-hed-2017

Date posted: May 28, 2021 | Author: Robert Plenge | No Comments »

Categories:

Leave a Reply Cancel reply

You must be logged in to post a comment.

Search for:

Recent Posts

Optimizing value creation in biopharma is like “the flop” in Texas hold ‘em
AI Unleashed: Transforming Drug Discovery from Theory to Practice
Advice to my younger self
Sequential immunotherapy for functional cures in autoimmunity
Increasing R&D productivity: “Bullseye, Aim, Fire!”

Recent Comments

ersutherland on Personalized medicine vs precision medicine
skathire on Mendelian randomization – differentiating between cause and consequence

Archives

Categories

Drug Discovery
Embedded Genomics
Human Genetics
Immunogenomics
Precision Medicine
Uncategorized

Tags

anti-sense oligonucleotide assay development biomarker causal human biology Cell cholesterol clinical trial COVID-19 CRISPR-cas9 cystic fibrosis drug development electronic health records epigenetics gene therapy genetics GWAS immunogenomics industry innovation JAMA loss-of-function mutations matching modality and mechanism mechanism of action (MOA) mendelian randomization Merck Nature Nature Genetics Nature Review Drug Discovery New England Journal of Medicine next-generation sequencing Parkinson's disease PCSK9 personalized medicine pharmacogenomics phenotype PheWAS polygenic precision medicine programmable therapeutics rare variants rheumatoid arthritis Science magazine Science Translational Medicine target validation TYK2

Meta

Log in
Entries feed
Comments feed
WordPress.org

Subscribe to this Blog

Enter your email address: